Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2001

View Archived Issues

MMP inhibition with batimastat reduces inflammation in experimental colitis

First case of linezolid-resistant Staphylococcus aureus infection reported

HIV protease inhibitors associated with lipoprotein alterations and endothelial dysfunction

Novel glycoalkaloid tomatine has potential as adjuvant in malaria vaccine development

Phogen signs licensing agreement with Genencor for VP22 technology

Avigen begins second phase I trial with Coagulin-B

FDA approves combination antihistamine/decongestant Zyrtec-D

Two antiangiogenesis agents from EntreMed receive orphan drug status

Phase II study of CETi-1 cholesterol vaccine from Avant initiated

E.C. clears Resovist via mutual recognition procedure

RenaGel receives marketing approval in Brazil

Active Biotech signs letter of intent with Avidex

Schwarz updates clinical trial programs

Optison product rights agreement amended

Praecis announces meeting date with FDA regarding Plenaxis NDA

Corixa and GSK submit complete response to FDA for Bexxar

Specific PPARgamma antagonist gives insight into receptor's role in adipogenesis

Roche discloses antiproliferative derivatives useful for the treatment of solid tumors

CRF receptor antagonists reported by researchers at Eisai

Schering-Plough identifies novel selective NK1 receptor antagonists

Grelan designs new series of PDE4 inhibitors

NPY5 receptor antagonists from Schering-Plough may be useful for treating obesity and diabetes

Natrecor launch quickly follows first approval in U.S.

Synthetic vitamin D3, ED-71, significantly increases BMD, BMC and bone strength

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...